e statements published on March 11, 2019, in which it is assured that the Mexican Social Security Institute (IMSS, by its acronym in Spanish) bought medicines for more than 526 million pesos to the company Marzam, pointing out an apparent conflict of interest, were stated as unsupported information. This was confirmed by Sergio Eduardo Huacuja Betancourt, Coordinator of the Anti-Corruption Committee of the Mexican Bar Association.